KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Net Cash Flow (2016 - 2026)

Edwards Lifesciences has reported Net Cash Flow over the past 17 years, most recently at $241.2 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 135.7% year-over-year to $241.2 million; the TTM value through Dec 2025 reached -$74.5 million, down 103.98%, while the annual FY2025 figure was -$74.5 million, 103.98% down from the prior year.
  • Net Cash Flow for Q4 2025 was $241.2 million at Edwards Lifesciences, up from -$594.2 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $2.1 billion in Q3 2024 and troughed at -$675.6 million in Q4 2024.
  • A 5-year average of $84.8 million and a median of $122.8 million in 2021 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: tumbled 460.89% in 2021 and later soared 827.79% in 2023.
  • Year by year, Net Cash Flow stood at -$654.3 million in 2021, then increased by 29.56% to -$460.9 million in 2022, then soared by 43.05% to -$262.5 million in 2023, then plummeted by 157.37% to -$675.6 million in 2024, then skyrocketed by 135.7% to $241.2 million in 2025.
  • Business Quant data shows Net Cash Flow for EW at $241.2 million in Q4 2025, -$594.2 million in Q3 2025, and $170.8 million in Q2 2025.